(Medical Xpress)—Researchers at the University of Michigan have found a new potential benefit of a molecule in green tea: preventing the misfolding of specific proteins in the brain.
Mar 5, 2013
2
0
Results of a major HIV prevention trial suggest that daily use of a product – whether a vaginal gel or an oral tablet – does not appear to be the right approach for preventing HIV in young, unmarried African women.
Mar 4, 2013
0
0
UT Arlington researchers are creating individualized, patient-centered rehabilitation software systems that will promote and support physical therapy for people with rheumatoid arthritis.
Mar 1, 2013
0
0
(Medical Xpress)—A possible link between colour vision and the development of myopia - or near-sightedness - has been discovered by an international group, including a researcher from The University of Western Australia.
Mar 1, 2013
0
0
Early life stress like that experienced by ill newborns appears to take an early toll of the heart, affecting its ability to relax and refill with oxygen-rich blood, researchers report.
Feb 21, 2013
0
0
An international multicenter clinical trial led by a Cedars-Sinai neurologist on the combination of brain cooling and "clot-busting" drug therapy after stroke has received Food and Drug Administration approval to expand from ...
Feb 6, 2013
0
0
The University of Michigan Cardiovascular Center and the University of Pittsburgh Medical Center will gain a new partner as it commences its study of earlier device use for patients with congestive heart failure.
Jan 15, 2013
0
0
(AP)—Texas Gov. Rick Perry has asked the embattled Cancer Prevention and Research Institute of Texas to stop giving grants until concerns about the beleaguered agency are resolved.
Dec 19, 2012
0
0
Better strategies are needed to help glaucoma patients cope with difficulty reading. According to a new scientific study published in Investigative Ophthalmology & Visual Science, adults with glaucoma read slower when reading ...
Dec 10, 2012
0
0
A previously invincible mutation in chronic myeloid leukemia (CML) has been thwarted by an investigational drug in a phase I clinical trial reported in the current edition of The New England Journal of Medicine.
Nov 28, 2012
0
0
